Skip to main content

Table 4 Known group validity testing: effect sizes (ES) of the differences within the testicular cancer sample between the known groups based on comorbidity status, age, education and marital status

From: International evaluation of the psychometrics of health-related quality of life questionnaires for use among long-term survivors of testicular and prostate cancer

  TCa survivors
Co-morbidities Age Education Marital status
0 comorbiditiesa 1 or more co-morbidities Younger than 40a 40–50 50 and older Universitya Higher education High school or less Singlea Partner
SF36: Physical Functioning   −0.66   −0.33 −0.41   −0.11 −0.58   0.61
SF36: Role-Physical   −0.62   −0.09 −0.12   −0.20 −0.24   0.93
SF36: Bodily Pain   −0.84   −0.34 −0.28   0.00 −0.14   0.64
SF36: General Health   −0.55   −0.37 −0.21   0.03 −0.16   0.74
SF36: Vitality   −0.61   −0.07 −0.13   0.13 −0.10   0.52
SF36: Social Functioning   −0.49   −0.10 0.17   −0.18 −0.10   0.93
SF36: Role-Emotional   −0.27   0.06 0.07   −0.21 −0.24   0.64
SF36: Mental Health   −0.20   0.37 0.58   −0.18 −0.11   0.65
QLQ-C30: Global health status/QoL   −0.36   −0.09 0.20   0.01 −0.29   0.67
QLQ-C30: Physical Function   −0.69   −0.29 −0.27   0.07 −0.42   0.75
QLQ-C30: Role Function   −0.55   −0.19 0.08   0.04 −0.43   0.90
QLQ-C30: Emotional Function   −0.48   0.01 0.17   0.04 −0.26   0.86
QLQ-C30: Cognitive Function   −0.48   −0.07 −0.30   −0.06 0.08   0.74
QLQ-C30: Social Function   −0.47   −0.07 0.12   0.14 0.01   0.66
QLQ-C30: Fatigue   −0.81   −0.07 −0.38   0.12 −0.31   0.76
QLQ-C30: Nausea / vomiting   −0.40   0.12 0.17   −0.12 −0.25   0.55
QLQ-C30: Pain   −0.80   −0.20 −0.19   0.13 −0.13   0.63
QLQ-C30: Dyspnoea   −0.45   −0.21 −0.40   0.27 −0.37   0.19
QLQ-C30: Insomnia   −0.43   0.15 0.14   −0.03 −0.04   0.73
QLQ-C30: Appetite loss   −0.17   0.06 0.10   0.04 −0.33   0.60
QLQ-C30: Constipation   −0.24   −0.10 −0.03   0.31 0.06   0.48
QLQ-C30: Diarrhoea   −0.03   −0.13 0.04   0.59 0.56   0.15
QLQ-C30: Financial problems   −0.37   0.06 −0.40   0.09 −0.12   0.41
IOC: Appearance concerns   −0.13   0.19 0.35   0.07 −0.07   0.31
IOC: Body change concerns   −0.41   −0.15 −0.32   −0.06 −0.30   0.34
IOC: Life interferences   −0.33   −0.01 −0.02   −0.07 −0.14   0.65
IOC: Worry   −0.42   −0.06 0.12   0.02 −0.19   0.23
IOC: Negative Impact Scale   −0.42   −0.04 0.04   −0.02 −0.25   0.50
TC26: Satisfaction with care   −0.23   −0.08 −0.17   0.02 0.03   −0.06
TC26: Future perspective   −0.32   0.01 0.07   −0.04 −0.36   0.52
TC26: Communication   0.05   0.16 −0.16   −0.22 −0.04   0.04
TC26: Sexual activity   −0.30   −0.17 −0.66   −0.19 −0.13   0.56
TC26: Sexual enjoyment   −0.30   0.00 −0.54   −0.15 −0.27   0.57
TC26: Satisfaction with testicular implant   −0.36   0.76 0.50   −0.09 −0.78   0.26
TC26: Treatment side effects   −0.57   −0.10 −0.08   −0.04 −0.14   0.52
TC26: Job problems   −0.34   −0.01 0.15   −0.02 −0.31   0.48
TC26: Family problems   −0.17   −0.05 0.07   0.18 −0.18   0.09
TC26: Infertility   0.06   0.70 1.07   0.14 0.04   0.23
TC26: Body Image   −0.26   0.31 0.14   0.36 0.01   0.54
TC26: Sexual problems   −0.38   0.17 −0.23   −0.19 −0.06   0.36
QPS: Work Motivation   −0.28   −0.05 0.49   −0.03 0.03   0.49
QPS: Job and life satisfaction   −0.21   −0.01 0.21   −0.03 0.05   0.51
QPS: Work ability   −0.37   −0.23 −0.50   −0.26 −0.37   0.59
QPS: Self-efficacy   −0.13   −0.41 −0.37   −0.28 −0.27   −0.27
  1. Effect sizes are displayed in bold in those cases where the known groups differed significantly (p ≤ .05). TCa testicular cancer
  2. A positive effect size reflects better HRQoL than the reference group, and a negative effect size reflects worse HRQoL than the reference group
  3. areference group